Delivered a dose to the right lobe instead of the intended left lobe [device deployment issue] case description: initial information received on 28-jul-2016: this spontaneous medical device report was received from a physician via a company representative and concerned a patient of unknown age and gender.The patient's medical history and concomitant medication were not provided.On an unspecified date the patient received therasphere (dose, indication, lot number and expiration date not reported).On an unspecified date the treating physicians had done a two month pet scan and confirmed that they delivered a dose to the right lobe instead of the left lobe.There was no patient impact at the time of the report.The outcome of the event was unknown.No other information available.Follow-up information is expected.The reporting physician did not assess the severity or the causality of the event.The company considers the event as serious (medically significant).Case comment: device deployment issue is considered unlisted according to the therasphere current reference safety information.Delivered a dose to the right lobe instead of the left lobe is not assessable as an event.This single case report does not modify the risk benefit balance of therasphere.The company is continuously monitoring all respective reports received and, based on cumulative experience, will re-evaluate the available evidence on an ongoing basis.
|
Delivered a dose to the right lobe instead of the intended left lobe [device deployment issue].Case description: initial information received on 28-jul-2016: this spontaneous medical device report was received from a physician via a company representative and concerned a patient of unknown age and gender.The patient's medical history and concomitant medication were not provided.On an unspecified date the patient received therasphere (dose, indication, lot number and expiration date not reported) on an unspecified date the treating physicians had done a two month pet scan and confirmed that they delivered a dose to the right lobe instead of the left lobe.There was no patient impact at the time of the report.The outcome of the event was unknown.No other information available.Follow-up information is expected.The reporting physician did not assess the severity or the causality of the event.The company considers the event as serious (medically significant).Follow-up information received on 11-aug-2016: the company representative reported that this incident was already reported on 24-may-2016.According to this new information, this case is a duplicate of (b)(4), all information was already included in (b)(4).This duplicate case will be therefore nullified.Case comment: device deployment issue is considered unlisted according to the therasphere current reference safety information.Delivered a dose to the right lobe instead of the left lobe is not assessable as an event.This single case report does not modify the risk benefit balance of therasphere.The company is continuously monitoring all respective reports received and, based on cumulative experience, will re-evaluate the available evidence on an ongoing basis.
|